CytoTerra Platform
Chromosomal Abnormalities in Cancer & Genetic Disease
CommercialActive
Key Facts
Indication
Chromosomal Abnormalities in Cancer & Genetic Disease
Phase
Commercial
Status
Active
Company
About Phase Genomics
Phase Genomics is a private biotechnology company that has commercialized a proprietary 'proximity ligation' (Hi-C) technology platform to enable ultra-long-range genome sequencing and analysis. Its three main product platforms—CytoTerra for cytogenetics, ProxiMeta for metagenome deconvolution, and Proximo for genome scaffolding—serve diverse markets including oncology, microbiology, and agricultural genomics. The company is in a revenue-generating stage, selling kits, software, and services to academic, biopharmaceutical, and agricultural research institutions globally.
View full company profile